11/24/2015 - 1:31pm

Eli Lilly and Co.’s Petrazza in a trial extended the lives of patients who took the drug in combination with two forms of chemotherapy to 11.5 months. 

11/24/2015 - 10:47am

Following Monday’s announcement that Pfizer would be merging with Ireland-based company Allergan, some analysts are predicting that Pfizer would split the combined company following the $160 billion deal, Reuters reported. According to the report, the split would likely divide the company’s established products (i.e., generics) unit and its innovative medicines unit, composed of drugs that are still patent-protected. (Reuters)

11/23/2015 - 4:10pm

The FDA has approved Bristol-Myers Squibb’s Opdivo as a treatment for renal cell carcinoma in some patients. 

11/23/2015 - 3:26pm

CVS Health has opted to only offer one of the two new PCSK9 inhibitors on its CVS/caremark commercial formularies. 

11/23/2015 - 2:57pm

The new indication provides another option for the estimated 300,000 patients who will undergo hip replacements in a year. 

11/23/2015 - 1:30pm

Perrigo is buying a Crohn’s disease treatment from AstraZeneca. 

11/23/2015 - 10:32am

A 15-member board composed will govern the combined company and Pfizer CEO Ian Read will be CEO of the combined company and Allergan CEO Brent Saunders will be the president and COO. 

11/20/2015 - 4:03pm

In preparation for this launch, Mission has expanded its sales force and increased promotional efforts to reach more primary care and internal medicine healthcare providers.

11/20/2015 - 3:55pm

Specialty medications represent only 1% of all prescriptions but, in 2014, these medications resulted in over 31% of all drug spending.